Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial
Weber, Jeffrey S, Gibney, Geoff, Sullivan, Ryan J, Sosman, Jeffrey A, Slingluff, Craig L, Lawrence, Donald P, Logan, Theodore F, Schuchter, Lynn M, Nair, Suresh, Fecher, Leslie, Buchbinder, ElizabethLangue:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(16)30126-7
Date:
June, 2016
Fichier:
PDF, 598 KB
english, 2016
File converter
Plus de résultats de recherche
More benefits 
